Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

RBC Capital Markets lowers target price on Dechra Pharmaceuticals

Thu, 15th Sep 2022 09:01

(Sharecast News) - Analysts at RBC Capital Markets lowered their target price on veterinary drugmaker Dechra Pharmaceuticals from 4,200.0p to 4,000.0p on Thursday following the group's full-year results a week earlier.

RBC Capital Markets said it had updated its model on Dechra after the results and to also reflect the firm's major acquisitions of Piedmont and Med-Pharmex.

For the 2023 and 2024 trading years, RBC said it was roughly 3.2% and 5.1% ahead of consensus on revenue, respectively, and 3.9% and 6.8% below on earnings per share estimates.

However, the Canadian bank said it sees "meaningful improvements" in the medium term with a 2023-26 earnings per share compound annual growth rate of 52%, and believes recent deals have "greater merit" than just the numbers alone, increasing Dechra's intrinsic value.

"We value Dechra in 18 months using a FY23e P/E of 29x and EV/EBITDA of 20x. These represent a 10% (from 15%) discount to market leader Zoetis due to Dechra's smaller size and lower growth rate," said RBC, which reiterated its 'outperform' rating on the stock.

"This leads to a fair value of £36 to which we add our risk-adjusted valuation of £4 for Dechra's novel portfolio pipeline, for a total of £40 (from £42 previously) with the move in PT driven mainly due to lower valuation multiples from peers."

Reporting by Iain Gilbert at Sharecast.com

More News
11 Jan 2022 12:19

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

LONDON MARKET MIDDAY: Stocks rise ahead of Powell's Senate hearing

Read more
11 Jan 2022 09:06

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook

LONDON MARKET OPEN: Stocks rise; Darktrace surges on bright outlook

Read more
11 Jan 2022 08:41

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug

Dechra Pharmaceuticals buys worldwide rights to verdinexor drug

Read more
11 Jan 2022 07:55

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises

LONDON MARKET PRE-OPEN: Games Workshop lifts dividend as revenue rises

Read more
4 Jan 2022 11:47

Dechra slumps as Exane highlights 'punchy valuation'

(Sharecast News) - Dechra Pharmaceuticals was under the cosh on Tuesday after Exane BNP Paribas initiated coverage of the stock at 'neutral' on valuation grounds.

Read more
4 Jan 2022 10:36

LONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK

LONDON BROKER RATINGS: JPMorgan lifts price targets for Dechra and GSK

Read more
4 Jan 2022 08:16

LONDON BRIEFING: dim t restaurant operator gives taste of Omicron hit

LONDON BRIEFING: dim t restaurant operator gives taste of Omicron hit

Read more
3 Dec 2021 09:44

LONDON BROKER RATINGS: Jefferies ups SSE, AJ Bell; Deutsche likes BP

LONDON BROKER RATINGS: Jefferies ups SSE, AJ Bell; Deutsche likes BP

Read more
1 Dec 2021 18:05

TOP NEWS: Electrocomponents, Dechra oust Darktrace and Johnson Matthey

TOP NEWS: Electrocomponents, Dechra oust Darktrace and Johnson Matthey

Read more
1 Dec 2021 14:44

Electrocomponents set for FTSE 100 as a founding member is seen ousted

Electrocomponents set for FTSE 100 as a founding member is seen ousted

Read more
23 Nov 2021 18:12

Dechra and Electrocomponents could be elevated to FTSE 100

Dechra and Electrocomponents could be elevated to FTSE 100

Read more
19 Nov 2021 14:56

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair

Read more
19 Nov 2021 07:34

Dechra Pharma selects Alison Platt as next chair

(Sharecast News) - Dechra Pharmaceuticals has selected Alison Platt to chair the board when Tony Rice steps down at the end of 2021.

Read more
12 Nov 2021 16:43

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
9 Nov 2021 22:01

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

TRADING UPDATES: Shepherd Neame losses cut; Beximco to sell Covid pill

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.